Drug Trial Radar · NCT06435221
Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers
Last checked: Nov 20, 2026Latest source record: Nov 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
479
Actual
Start
May 28, 2024
Primary completion
Sep 29, 2025
Study completion Oct 6, 2025
Sponsor
- Lead sponsor
- Achieve Life SciencesIndustry
- Sponsor type
- Industry
- First posted
- May 30, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Safety assessment of long-term 3 mg cytisinicline three times daily (TID) exposure for 52 weeks is the main purpose of this study, conducted in the United States.
Conditions
- Smoking Cessation
- Vaping Cessation
Interventions
CytisiniclineDrug
film-coated oral tablets containing 3 mg cytisinicline
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence Rate of Treatment Emergent Serious Adverse Events (SAEs)Time frame: up to Week 52
Locations
29 sites in 1 country. Site status is shown where the registry gives one.
Alliance for Multispecialty Research, LLC
Mobile, Alabama
Alliance for Multispecialty Research, LLC
Tempe, Arizona
Little Rock Allergy & Asthma Clinical Research Center
Little Rock, Arkansas
Alliance for Multispecialty Research, LLC
Coral Gables, Florida
Accel Research Sites Network - DeLand Clinical Research Unit
DeLand, Florida
Alliance for Multispecialty Research, LLC
Fort Myers, Florida
Jacksonville Center for Clinical Research
Jacksonville, Florida
Precision Clinical Research
Sunrise, Florida
Clinical Research Atlanta
Stockbridge, Georgia
Alliance for Multispecialty Research, LLC
Oak Brook, Illinois
MediSphere Medical Research Center, LLC
Evansville, Indiana
Alliance for Multispecialty Research, LLC
Wichita, Kansas
Alliance for Multispecialty Research, LLC
Lexington, Kentucky
Alliance for Multispecialty Research, LLC
New Orleans, Louisiana
Massachusetts General Hospital - Clinical Genetic Facility
Boston, Massachusetts
Insight Research Institute
Flint, Michigan
Alliance for Multispecialty Research, LLC
Kansas City, Missouri
Alliance for Multispecialty Research, LLC
Las Vegas, Nevada
Global Medical Institutes LLC; Princeton Medical Institute
Princeton, New Jersey
Rochester Clinical Research, LLC
Rochester, New York
Centricity Research Columbus Ohio Multispecialty
Columbus, Ohio
Alliance for Multispecialty Research, LLC
Norman, Oklahoma
Altoona Center for Clinical Research
Duncansville, Pennsylvania
Coastal Carolina Research Center
North Charleston, South Carolina
Alliance for Multispecialty Research, LLC
Knoxville, Tennessee
Clinical Research Associates, Inc.
Nashville, Tennessee
Clinical Trials of Texas, LLC
San Antonio, Texas
Health Research of Hampton Roads, Inc.
Newport News, Virginia
Alliance for Multispecialty Research, LLC
Norfolk, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.